Dizziness from standing up may mean higher risk of dementia
People with orthostatic hypotension in middle age had 54% higher risk of developing dementia Related items fromOnMedica Hypertension raises risk of mitral regurgitation Dementia and stroke funding remains too low, say experts Stroke can often be avoided, claims study Adding insulin to metformin linked to higher mortality Stroke rates rocket in younger men and women (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 26, 2018 Category: UK Health Source Type: news

Sulfonylureas As 2nd-Line T2DM Therapy Tied to Higher Event Risk
TUESDAY, July 24, 2018 -- Sulfonylureas as second-line drugs for type 2 diabetes are associated with an increased risk of cardiovascular and hypoglycemic events compared with remaining on metformin monotherapy or adding to metformin therapy,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 24, 2018 Category: Pharmaceuticals Source Type: news

Medical News Today: Diabetes: Switching to common drugs raises risk of complications
A new study finds that switching from metformin to sulfonylureas to control blood sugar levels may significantly increase the risk of major complications. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 19, 2018 Category: Consumer Health News Tags: Diabetes Type 2 Source Type: news

Switching from metformin to sulfonylurea linked to cardiometabolic complications
For type-2 diabetes patients, continuing metformin treatment together with sulfonylurea is safer than switching from one to the other, a study inThe BMJ reports.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 19, 2018 Category: Endocrinology Source Type: news

Adding or Switching Diabetes Drugs Can Put Patients at Risk: Study
THURSDAY, July 19, 2018 -- Using sulfonylurea drugs with or instead of metformin to control blood sugar increases type 2 diabetics'risk of serious complications, a new study finds. Metformin is a first-line treatment for type 2 diabetes, meaning it... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - July 19, 2018 Category: General Medicine Source Type: news

Raised risk of MI and mortality when starting sulfonylurea
Continuing metformin when introducing sulfonylureas in type 2 diabetes safer than switching Related items fromOnMedica Sugar not saturated fat is the major issue for CVD Experts query risks of pioglitazone Regulators suspend Avandia over safety concerns Daily aspirin use linked to major bleeding Use of DPP-4 inhibitors associated with increased risk of IBD (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 19, 2018 Category: UK Health Source Type: news

Switching From Metformin to Sulfonylurea Raises CV Risks Switching From Metformin to Sulfonylurea Raises CV Risks
In patients with type 2 diabetes not at glycemic goal, adding a sulfonylurea to metformin appears to be much safer than switching.Medscape Medical News (Source: Medscape Diabetes Headlines)
Source: Medscape Diabetes Headlines - July 18, 2018 Category: Endocrinology Tags: Diabetes & Endocrinology News Source Type: news

Metformin Beats Sulfonylureas for Heart Safety in T2D
(MedPage Today) -- MI risk seen with switch to sulfonylurea monotherapy or add-on treatment (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 18, 2018 Category: Primary Care Source Type: news

Two Regimens Fail to Stop Declines in & #946;-Cell Function
FRIDAY, July 13, 2018 -- Neither glargine followed by metformin nor metformin alone halts the progressive deterioration of β-cell function in youth with impaired glucose tolerance (IGT) or recently-diagnosed type 2 diabetes, according to a study... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 13, 2018 Category: Pharmaceuticals Source Type: news

Metformin Tied to Acidosis Risk at eGFR & #60;30mL/min/1.73 m & #178;
WEDNESDAY, July 11, 2018 -- Metformin use is associated with an increased risk of acidosis at estimated glomerular filtration rate (eGFR)
Source: Drugs.com - Pharma News - July 11, 2018 Category: Pharmaceuticals Source Type: news

Standard type 2 diabetes treatments may not improve the condition in youth
Taking insulin or the most commonly used drug for type 2 diabetes, metformin, failed to either delay or effectively treat the condition in youth. (Source: Yale Science and Health News)
Source: Yale Science and Health News - July 10, 2018 Category: Universities & Medical Training Source Type: news

Metformin may help treatment of lung fibrosis
The diabetes drug could help reverse established lung fibrosis, a condition that currently lacks effective treatment options, according to a study inNature Medicine.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - July 4, 2018 Category: Endocrinology Source Type: news

Metformin reverses lung fibrosis in study with mice
Lung fibrosis was reversed in mice using metformin, a drug that has long been used to treat diabetes, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - July 3, 2018 Category: Consumer Health News Source Type: news

Sitagliptin-Metformin Therapy in Prior Gestational Diabetics Sitagliptin-Metformin Therapy in Prior Gestational Diabetics
Find out about the benefits treatment with sitagliptin combined with metformin may provide prediabetic women with a history of gestational diabetes.Endocrine Practice (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 3, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news

Youth-Onset Diabetes Needs Different Approach to That in Adults Youth-Onset Diabetes Needs Different Approach to That in Adults
Disturbing findings from the RISE study show that treating youth who have prediabetes with insulin and/or metformin doesn't prevent beta-cell deterioration; better treatments are needed, say physicians.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 27, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Metformin Linked to Lower Mortality in Diabetes With Dementia Metformin Linked to Lower Mortality in Diabetes With Dementia
A large registry study shows a 15% reduction in overall mortality among patients with diabetes and dementia who used metformin, while those taking insulin had an increased rate of heart failure.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 26, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Early T2D Treatment in Youth Disappoints
(MedPage Today) -- Metformin, insulin didn't stop deterioration of beta-cells in adolescents with impaired glucose (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - June 25, 2018 Category: Cardiology Source Type: news

metformin (Glucophage, Glucophage XR, Glumetza, Fortamet, Riomet)
Title: metformin (Glucophage, Glucophage XR, Glumetza, Fortamet, Riomet)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 6/25/2018 12:00:00 AM (Source: MedicineNet Diabetes General)
Source: MedicineNet Diabetes General - June 25, 2018 Category: Endocrinology Source Type: news

Love Affair With Metformin: Still Strong, or Time to Move On? Love Affair With Metformin: Still Strong, or Time to Move On?
Should metformin remain first line for the treatment of type 2 diabetes or not? That was the question. Passions were high during this entertaining debate in one of the first sessions at ADA this year.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 23, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

How An Old Diabetes Drug Made A Big Splash At The Biggest Cancer Confab
Metformin has been used for the last two decades to lower blood sugar in patients with type 2 diabetes. But the drug may find a second life in cancer care. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - June 7, 2018 Category: Pharmaceuticals Authors: Arlene Weintraub, Contributor Source Type: news

Metformin safe for most diabetics with kidney disease
Metform, a longtime and low-cost drug used to treat diabetes, is safe for most patients who also have chronic kidney disease, according to new research. (Source: Health News - UPI.com)
Source: Health News - UPI.com - June 5, 2018 Category: Consumer Health News Source Type: news

Evidence Growing Metformin Safe in Many With Diabetes and CKD Evidence Growing Metformin Safe in Many With Diabetes and CKD
Rates of acidosis comparable in metformin-treated and nontreated patients with type 2 diabetes and mild to moderate chronic kidney disease when eGFR is at least 30 mL/min/1.73 m2.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 5, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

Metformin therapy safe in chronic kidney disease patients
In patients with mild, moderate chronic kidney disease, the use of metformin does not increase lactic acidosis, according to a study inJAMA Internal Medicine.Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - June 5, 2018 Category: Endocrinology Source Type: news

Common diabetes drug found safe for most diabetics with kidney disease
(Johns Hopkins Medicine) Results of a large-scale study suggest that the oral diabetes drug metformin is safe for most diabetics who also have chronic kidney disease (CKD). The study of more than 150,000 adults by Johns Hopkins Medicine investigators found that metformin's association with the development of a life-threatening condition called lactic acidosis was seen only among patients with severely decreased kidney function. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 5, 2018 Category: International Medicine & Public Health Source Type: news

Computer simulations identify chemical key to diabetes drug alternatives
(University of Tennessee at Knoxville) Jeremy Smith, Governor's Chair for Molecular Biophysics at the University of Tennessee, Knoxville, and director of the Center for Molecular Biophysics at Oak Ridge National Laboratory, has worked with a research team from the UT Health Science Center to discover a chemical compound that could lower sugar levels as effectively as the diabetes drug metformin but with a lower dose. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 5, 2018 Category: International Medicine & Public Health Source Type: news

Metformin could ‘help millions with heart and circulatory disease’
Metformin – the cheap drug routinely used for the treatment of type 2 diabetes – could also help millions of other patients with cardiovascular conditions in the UK, according to researchers. (Source: Nursing Times)
Source: Nursing Times - June 4, 2018 Category: Nursing Source Type: news

A cheap 1p diabetes pill can stop heart attacks and strokes
Two British studies found that those taking the drug metformin – which costs as little as 1p a pill – had lower blood pressure, lost weight and saw harmful thickening of the heart reversed. (Source: the Mail online | Health)
Source: the Mail online | Health - June 4, 2018 Category: Consumer Health News Source Type: news

Metformin Reduces Mild Statin-Induced Myalgia
Risk of non-severe statin muscle pain reduced in T2DM patients taking both metformin and statins, according to this recent study.   (Source: ConsultantLive)
Source: ConsultantLive - May 15, 2018 Category: Internal Medicine Authors: Gregory M. Weiss, MD Source Type: news

Diabetes: Is THIS drug hiding a deadly secret?
EVERY year, 20 million prescriptions are written for metformin, a glucose-lowering medicine taken by 90 per cent of the three million Britons diagnosed with Type 2 diabetes. (Source: Daily Express - Health)
Source: Daily Express - Health - May 15, 2018 Category: Consumer Health News Source Type: news

Menstrual Dysfunction Common in Youth-Onset T2D (CME/CE)
(MedPage Today) -- PCOS may also be present, but masked by metformin treatment (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - April 25, 2018 Category: Cardiology Source Type: news

Two New Drug Classes Tied to Better Survival in Type 2 Diabetes Two New Drug Classes Tied to Better Survival in Type 2 Diabetes
Based on a network meta-analysis, SGLT-2 inhibitors and GLP-1 agonists may be preferred over DPP-4 inhibitors as add-on therapies to metformin for type 2 diabetes, researchers report.Medscape Medical News (Source: Medscape FamilyMedicine Headlines)
Source: Medscape FamilyMedicine Headlines - April 18, 2018 Category: Primary Care Tags: Diabetes & Endocrinology News Source Type: news

Most widely prescribed diabetes drug improves nicotine withdrawal symptoms in animal model
(University of Pennsylvania School of Medicine) Metformin, the most widely used medication for diabetes, has also been shown to help treat dementia and some cancers. New research shows smoking cessation may be added to that list. The research team found that after giving mice metformin the animals displayed reduced symptoms when going through nicotine withdrawal. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 12, 2018 Category: International Medicine & Public Health Source Type: news

My T2DM Patient is Not at Goal with Metformin . . . What ’s Next?
A 52-year-old woman with T2DM is on metformin, works with a dietitian, and excercises regularly, but her hemoglobin A1c has increased. What would you advise?   (Source: ConsultantLive)
Source: ConsultantLive - April 10, 2018 Category: Internal Medicine Authors: Edward C. Chao Tags: Diabetes T2 Diabetes Source Type: news

Type 2 diabetes drug Metformin may help treat nicotine withdrawal
Researchers at Johns Hopkins University found that metformin, a drug used to treat type 2 diabetes, could prevent symptoms of nicotine withdrawal, such as cravings and fatigue. (Source: the Mail online | Health)
Source: the Mail online | Health - April 5, 2018 Category: Consumer Health News Source Type: news

Study: Diabetes drug metformin may help with nicotine withdrawal
Metformin, besides commonly treating people with type 2 diabetes, might help curb nicotine withdrawal without side effects, according to a study of mice. (Source: Health News - UPI.com)
Source: Health News - UPI.com - April 5, 2018 Category: Consumer Health News Source Type: news

Herbal and fruit supplement found to be more effective at managing diabetes than metformin drug
(Natural News) Type 2 diabetes can be a tricky illness to manage. In many cases, it is entirely possible to keep it under control with proper diet and regular exercise, and the lack of side effects makes this the most prudent approach for many people. However, others turn to diabetes drugs like Metformin to manage... (Source: NaturalNews.com)
Source: NaturalNews.com - April 2, 2018 Category: Consumer Health News Source Type: news

Use of most-prescribed diabetes drug, metformin, during pregnancy found to increase risk of obesity in the child
(Natural News) According to the results of a study, women who take metformin, a common diabetes medication, could be putting their children at increased risk of being obese or overweight. More pregnant women with gestational diabetes or polycystic ovary syndrome (PCOS) are taking metformin to treat their conditions. PCOS usually causes infertility, and the condition can put... (Source: NaturalNews.com)
Source: NaturalNews.com - March 26, 2018 Category: Consumer Health News Source Type: news

Metformin May Prevent Pregnancy Complications in PCOS Metformin May Prevent Pregnancy Complications in PCOS
In women with polycystic ovary syndrome, metformin treatment during pregnancy cut the risks for late miscarriage and preterm birth, but didn't prevent gestational diabetes.Medscape Medical News (Source: Medscape ObGyn and Womens Health Headlines)
Source: Medscape ObGyn and Womens Health Headlines - March 22, 2018 Category: OBGYN Tags: Diabetes & Endocrinology News Source Type: news

Metformin use may lower pregnancy complications in PCOS
New research presented at ENDO 2018 suggests that women who suffer from PCOS, and use metformin during pregnancy, are at a lower risk of late miscarriage and premature birth.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - March 21, 2018 Category: Endocrinology Source Type: news

Metformin, Statins Not Linked With Ovarian Cancer Risk in Diabetic Patients
A large study found no association between the use of metformin or statins and the incidence of ovarian cancer in women with type 2 diabetes. (Source: CancerNetwork)
Source: CancerNetwork - March 16, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Gynecologic Cancers News Ovarian Cancer Source Type: news

Medical News Today: How an existing diabetes drug controls pancreatic cancer
A new study suggests that targeting the RET signaling pathway with metformin might offer a new way to stop the growth and spread of pancreatic cancer. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - March 15, 2018 Category: Consumer Health News Tags: Pancreatic Cancer Source Type: news

NIH-funded study: Early, intensive treatment may be needed for some youth with type 2 diabetes
Inability of youth with type 2 diabetes to get blood glucose levels into a nondiabetic range shortly after using metformin alone may be due to genetics. (Source: NIDDK News)
Source: NIDDK News - March 15, 2018 Category: Endocrinology Source Type: news

New Mechanism Proposed for Glucose-lowering Effect of Metformin, a Drug for Type 2 Diabetes
Evidence that metformin tampers with glucagon-induced glucose output by disrupting glucagon signaling in liver cells may lead to new type 2 diabetes treatments. (Source: NIDDK News)
Source: NIDDK News - March 15, 2018 Category: Endocrinology Source Type: news

Metformin use during pregnancy linked to heavier babies
A study in theJournal of Clinical Endocrinology& Metabolism reports that PCOS patients who take metformin during pregnancy are more likely to have heavier babies.Medpage Today (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 28, 2018 Category: Endocrinology Source Type: news

Metformin in Pregnancy Tied to Heavier Toddlers
(MedPage Today) -- Effect seen in mothers with PCOS, gestational diabetes (Source: MedPage Today Endocrinology)
Source: MedPage Today Endocrinology - February 27, 2018 Category: Endocrinology Source Type: news

Norwegian study reveals metformin can make children fat
Children whose mothers used metformin during pregnancy weighed more when they turned four, by around 1lb 12oz (0.8kg), Norwegian University of Science and Technology in Trondheim experts found. (Source: the Mail online | Health)
Source: the Mail online | Health - February 27, 2018 Category: Consumer Health News Source Type: news

Metformin in Pregnancy May Increase Childhood Obesity Risk Metformin in Pregnancy May Increase Childhood Obesity Risk
Women with polycystic ovary syndrome who take metformin during pregnancy appear to be more likely to have children who are overweight or obese, a follow-up of two Norwegian trials suggests.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 27, 2018 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news

No Link Found for Metformin or Statins and Ovarian Cancer
Findings based on a Finnish study involving a national cohort of women with type 2 diabetes (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - February 27, 2018 Category: Cancer & Oncology Tags: Cardiology, Endocrinology, Family Medicine, Gynecology, Internal Medicine, Nursing, Oncology, Pharmacy, Journal, Source Type: news

Clinical and laboratory features of metformin intoxication in suicidal patients attending an intensive care unit - Cetinkaya A, Avci D, Erden A, Akca O, Ozer O, Kalan U, Gunal AI.
This study has been performed for the purpose of researching the complications occurred at patients who took metformin overdose in an attempt to suicide. None of the patients has the diagnosis of diabetes mellitus and never used metformin. ... (Source: SafetyLit)
Source: SafetyLit - February 26, 2018 Category: International Medicine & Public Health Tags: Poisoning Source Type: news

Prandimet (Repaglinide and Metformin HCl Tablets) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - February 12, 2018 Category: Drugs & Pharmacology Source Type: news